retatrutide pharmacokinetics The novel GIP, GLP‐1 and glucagon receptor agonist delays gastric emptying - Urva - 2023 - Diabetes, Obesity and Metabolism Pharmacokinetic behavior of ALT-801 and

doi: 10.2337/diab.47.1.57 23 HolzGLeechCAHabenerJF

PubMed, doi:10.1038/s41397-018-0023-7

The study utilized a single-blind, randomized, placebo-controlled, crossover design, combined with functional magnetic resonance imaging (fMRI), to analyze the performance of 54 participants (30 with normal insulin sensitivity and 24 with impaired insulin sensitivity) on sensory associative learning tasks while receiving liraglutide and placebo treatments

Structurally, it is a 39-amino acid modified peptide, attached to a C20 fatty diacid moiety, which facilitates albumin binding

Curr Gene Ther 12(3):245259 Yoon JH, Kwon KS (2021) Receptor-mediated muscle homeostasis as a target for sarcopenia therapeutics

TRIUMPH-2 and TRIUMPH-3 results expected in 2026 may provide answers about dysesthesia's natural history and whether it's temporary or permanent